| Segmented regression analysis of interrupted time series studies in medication use research AK Wagner, SB Soumerai, F Zhang, D Ross‐Degnan Journal of clinical pharmacy and therapeutics 27 (4), 299-309, 2002 | 3271 | 2002 |
| Translating health status questionnaires and evaluating their quality: the IQOLA project approach M Bullinger, J Alonso, G Apolone, A Leplège, M Sullivan, ... Journal of clinical epidemiology 51 (11), 913-923, 1998 | 1387 | 1998 |
| International quality of life assessment (IQOLA) project NK Aaronson, C Acquadro, J Alonso, G Apolone, D Bucquet, M Bullinger, ... Quality of life research 1, 349-351, 1992 | 1003 | 1992 |
| Essential medicines for universal health coverage VJ Wirtz, HV Hogerzeil, AL Gray, M Bigdeli, CP de Joncheere, MA Ewen, ... The Lancet 389 (10067), 403-476, 2017 | 636 | 2017 |
| Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA project AK Wagner, B Gandek, NK Aaronson, C Acquadro, J Alonso, G Apolone, ... Journal of clinical epidemiology 51 (11), 925-932, 1998 | 411 | 1998 |
| Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? AK Wagner, F Zhang, SB Soumerai, AM Walker, JH Gurwitz, RJ Glynn, ... Archives of internal medicine 164 (14), 1567-1572, 2004 | 315 | 2004 |
| Simulation-based power calculation for designing interrupted time series analyses of health policy interventions F Zhang, AK Wagner, D Ross-Degnan Journal of clinical epidemiology 64 (11), 1252-1261, 2011 | 277 | 2011 |
| Methods for estimating confidence intervals in interrupted time series analyses of health interventions F Zhang, AK Wagner, SB Soumerai, D Ross-Degnan Journal of clinical epidemiology 62 (2), 143-148, 2009 | 258 | 2009 |
| Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey AK Wagner, AJ Graves, SK Reiss, R LeCates, F Zhang, D Ross-Degnan Health policy 100 (2-3), 151-158, 2011 | 200 | 2011 |
| Medicines use in primary care in developing and transitional countries: fact book summarizing results from studies reported between 1990 and 2006 World Health Organization World Health Organization, 2009 | 173* | 2009 |
| Potentially inappropriate medication use by elderly persons in US Health Maintenance Organizations, 2000–2001 SR Simon, KA Chan, SB Soumerai, AK Wagner, SE Andrade, ... Journal of the American Geriatrics Society 53 (2), 227-232, 2005 | 155 | 2005 |
| Have we improved use of medicines in developing and transitional countries and do we know how to? Two decades of evidence KA Holloway, V Ivanovska, AK Wagner, C Vialle‐Valentin, ... Tropical Medicine & International Health 18 (6), 656-664, 2013 | 143 | 2013 |
| Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer L Nekhlyudov, L Li, D Ross-Degnan, AK Wagner Breast cancer research and treatment 130, 681-689, 2011 | 128 | 2011 |
| Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life AK Wagner, SD Keller, M Kosinski, GA Baker, A Jacoby, MA Hsu, ... Quality of Life Research 4, 115-134, 1995 | 128 | 1995 |
| Health insurance systems in five Sub-Saharan African countries: medicine benefits and data for decision making JL Carapinha, D Ross-Degnan, AT Desta, AK Wagner Health policy 99 (3), 193-202, 2011 | 123 | 2011 |
| Patient-based health status measurement in clinical practice: a study of its impact on epilepsy patients' care AK Wagner, BL Ehrenberg, TA Tran, KM Bungay, DJ Cynn, WH Rogers Quality of Life Research 6, 329-341, 1997 | 117 | 1997 |
| FDA drug prescribing warnings: is the black box half empty or half full? AK Wagner, KA Chan, I Dashevsky, MA Raebel, SE Andrade, JE Lafata, ... Pharmacoepidemiology and drug safety 15 (6), 369-386, 2006 | 115 | 2006 |
| Medicine access and utilization in a population covered by primary health care in Brazil AD Bertoldi, AJD de Barros, A Wagner, D Ross-Degnan, PC Hallal Health policy 89 (3), 295-302, 2009 | 105 | 2009 |
| Payers’ experiences with confidential pharmaceutical price discounts: a survey of public and statutory health systems in North America, Europe, and Australasia SG Morgan, S Vogler, AK Wagner Health Policy 121 (4), 354-362, 2017 | 101 | 2017 |
| Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China Y Fang, AK Wagner, S Yang, M Jiang, F Zhang, D Ross-Degnan The Lancet Global Health 1 (4), e227-e237, 2013 | 99 | 2013 |
Dennis Ross-DegnanHarvard Medical School and Harvard Pilgrim Health Care Institute在 hms.harvard.edu 的电子邮件经过验证
